SCHEMBL12200517

SCHEMBL12200517

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c3ccc3c5cccc6c5c(cc43)-c3ccccc3-6)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
L3MBTL1 Q9Y468 5/20 0.50
TSHR P16473 4/20 0.50
HPGD P15428 4/20 0.50
MAPK1 P28482 3/20 0.50
HSD17B10 Q99714 3/20 0.50
CASP1 P29466 1/20 0.50
HIF1A Q16665 1/20 0.50
ADORA2A P29274 4/20 0.40
ADORA1 P30542 4/20 0.40
ADORA3 P0DMS8 2/20 0.40
ADORA2B P29275 2/20 0.40
ALOX15 P16050 1/20 0.40
MAPT P10636 3/20 0.39
ATM Q13315 3/20 0.39
KDM4E B2RXH2 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
TP53 P04637 1/20 0.39
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12200441 0.95 ALDH1A1 (0.51) ALDH1A1L3MBTL1TSHRHPGDMAPK1
SCHEMBL20624286 0.88 ALDH1A1 (0.44) ALDH1A1L3MBTL1TSHRHPGDMAPK1
SCHEMBL17692174 0.88 ALDH1A1 (0.40) ALDH1A1L3MBTL1TSHRHPGDMAPK1
SCHEMBL17692173 0.87 ALDH1A1 (0.39) ALDH1A1L3MBTL1TSHRHPGDMAPK1
SCHEMBL23546599 0.85 CRHBP (0.46) ALDH1A1L3MBTL1TSHRHPGDMAPK1
SCHEMBL12200431 0.85 CRHBP (0.46) ALDH1A1L3MBTL1TSHRHPGDMAPK1
SCHEMBL19501143 0.85 TSHR (0.45) ALDH1A1L3MBTL1TSHRHPGDMAPK1
SCHEMBL12200449 0.85 L3MBTL1 (0.47) ALDH1A1L3MBTL1TSHRHPGDMAPK1
SCHEMBL16158650 0.85 L3MBTL1 (0.50) ALDH1A1L3MBTL1TSHRHPGDMAPK1
SCHEMBL22851317 0.83 TSHR (0.44) ALDH1A1L3MBTL1TSHRHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8765270-B2 Triazine compound and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2014-07-01 US disclosed
US-8765270-B2 Triazine compound and organic light emitting device using the same CANON KABUSHIKI KAISHA (JP) 2014-07-01 US disclosed
US-20110240983-A1 TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-10-06 US disclosed
US-20110240983-A1 TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CANON KABUSHIKI KAISHA (JP) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110240983-A1 TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME TERT, CYP1A1, NR2E3 ALDH1A1 44/4885L3MBTL1 1076/4885TSHR 952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.